Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03060074 19-HETE cPLA2i 1.0 BCD110605C28 1.09 pmol/ml medium
LMFA03060074 19-HETE cPLA2i 1.0 BCD110605C30 0.937 pmol/ml medium
LMFA03060074 19-HETE cPLA2i 1.0 BCD110605C29 1.07 pmol/ml medium
LMFA03060074 19-HETE cPLA2i 20.0 BCD110605C64 1.15 pmol/ml medium
LMFA03060074 19-HETE cPLA2i 20.0 BCD110605C66 1.12 pmol/ml medium
LMFA03060074 19-HETE cPLA2i 20.0 BCD110605C65 1.1 pmol/ml medium
LMFA03060074 19-HETE PLDi 1.0 BCD110605C16 0.954 pmol/ml medium
LMFA03060074 19-HETE PLDi 1.0 BCD110605C17 0.927 pmol/ml medium
LMFA03060074 19-HETE PLDi 1.0 BCD110605C18 1.15 pmol/ml medium
LMFA03060074 19-HETE PLDi 20.0 BCD110605C54 1.31 pmol/ml medium
LMFA03060074 19-HETE PLDi 20.0 BCD110605C52 1.27 pmol/ml medium
LMFA03060074 19-HETE PLDi 20.0 BCD110605C53 1.04 pmol/ml medium
LMFA03060074 19-HETE KDO+cPLA2i 1.0 BCD110605C32 1.23 pmol/ml medium
LMFA03060074 19-HETE KDO+cPLA2i 1.0 BCD110605C31 0.796 pmol/ml medium
LMFA03060074 19-HETE KDO+cPLA2i 1.0 BCD110605C33 1.2 pmol/ml medium
LMFA03060074 19-HETE KDO+cPLA2i 20.0 BCD110605C68 0.844 pmol/ml medium
LMFA03060074 19-HETE KDO+cPLA2i 20.0 BCD110605C69 0.981 pmol/ml medium
LMFA03060074 19-HETE KDO+cPLA2i 20.0 BCD110605C67 0.86 pmol/ml medium
LMFA03060074 19-HETE KDO+PLDi 1.0 BCD110605C19 1.05 pmol/ml medium
LMFA03060074 19-HETE KDO+PLDi 1.0 BCD110605C20 0.896 pmol/ml medium
LMFA03060074 19-HETE KDO+PLDi 1.0 BCD110605C21 1.02 pmol/ml medium
LMFA03060074 19-HETE KDO+PLDi 20.0 BCD110605C56 1.1 pmol/ml medium
LMFA03060074 19-HETE KDO+PLDi 20.0 BCD110605C57 1.16 pmol/ml medium
LMFA03060074 19-HETE KDO+PLDi 20.0 BCD110605C55 0.958 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+cPLA2i 1.0 BCD110605C37 1.2 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.849 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+cPLA2i 1.0 BCD110605C39 1.03 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+cPLA2i 20.0 BCD110605C74 1.1 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.862 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+cPLA2i 20.0 BCD110605C73 1.15 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+PLDi 1.0 BCD110605C25 0.888 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+PLDi 1.0 BCD110605C27 0.965 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+PLDi 1.0 BCD110605C26 0.954 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+PLDi 20.0 BCD110605C61 1.09 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+PLDi 20.0 BCD110605C62 1.03 pmol/ml medium
LMFA03060074 19-HETE KDO+ATP+PLDi 20.0 BCD110605C63 1.19 pmol/ml medium
LMFA03060074 19-HETE KDO + ATP 1.0 BCD110605C15 1.12 pmol/ml medium
LMFA03060074 19-HETE KDO + ATP 1.0 BCD110605C14 1.01 pmol/ml medium
LMFA03060074 19-HETE KDO + ATP 1.0 BCD110605C13 1.01 pmol/ml medium
LMFA03060074 19-HETE KDO + ATP 20.0 BCD110605C49 1.01 pmol/ml medium
LMFA03060074 19-HETE KDO + ATP 20.0 BCD110605C50 1.17 pmol/ml medium
LMFA03060074 19-HETE KDO + ATP 20.0 BCD110605C51 1.32 pmol/ml medium
LMFA03060074 19-HETE KDO 1.0 BCD110605C08 0.947 pmol/ml medium
LMFA03060074 19-HETE KDO 1.0 BCD110605C07 0.803 pmol/ml medium
LMFA03060074 19-HETE KDO 1.0 BCD110605C09 0.881 pmol/ml medium
LMFA03060074 19-HETE KDO 20.0 BCD110605C45 1.1 pmol/ml medium
LMFA03060074 19-HETE KDO 20.0 BCD110605C44 1.04 pmol/ml medium
LMFA03060074 19-HETE KDO 20.0 BCD110605C43 1.26 pmol/ml medium
LMFA03060074 19-HETE C 0.0 BCD110605C03 1.24 pmol/ml medium
LMFA03060074 19-HETE C 0.0 BCD110605C01 1.48 pmol/ml medium